Overview

This trial is active, not recruiting.

Condition foot ulcer, diabetic
Treatments "temp touch" diabetica solutions inc., inspection
Sponsor Oslo University Hospital
Start date June 2009
End date September 2013
Trial size 40 participants
Trial identifier NCT01269502, 20, 6.2009.60

Summary

A randomised controlled pilot study on the feasibility of introducing a skin temperature device (Temp Touch) in secondary prevention of foot ulcers in people with diabetes who have had a foot ulcer in Norway.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking single blind (outcomes assessor)
Primary purpose prevention
Arm
(Experimental)
Regular measurement of skin temperature on feet for one year
"temp touch" diabetica solutions inc. "Temp Touch" Diabetica Solutions inc.
Daily measurement of skin temperature on feet for one year
(Active Comparator)
Daily inspection of feet for one year
inspection Inspection
Inspection of feet daily for one year

Primary Outcomes

Measure
Recurrency of diabetic foot ulcer
time frame: One year

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: - Previous neuropathic diabetic foot ulcer Exclusion Criteria: - Ankle/brachial index < 0.7. Osteomyelitis, active Charcot

Additional Information

Official title Prevention of Secondary Foot Ulcers in Patients With Diabetes. Will People With Diabetes Who Have Had a Foot Ulcer be Able to Prevent Secondary Ulcers by Systematically Measuring Their Skin Temperature?
Principal investigator Bente K Kilhovd, Md, PhD
Description Diabetes mellitus is linked to late complications from kidneys, eyes, nerves, feet, and an increased risk of cardiovascular disease. Approximately 170 000 people in Norway suffer from diabetes, and diabetic foot disease is one of the most common complications. It is estimated that between 400 and 500 amputations are performed yearly in Norway, and most of the amputations are due to non-healing diabetic foot ulcers. Efficient prevention in high-risk individuals includes follow-up in specialist foot clinics including training in self-care, adaptation of preventive footwear and insoles. A randomised trial testing the use of skin temperature measurement in addition to routine foot care for preventing new foot ulcers showing a highly significant reduction in recurrent foot ulcers in the temperature measuring group, has previously been performed in USA (Lavery et al. Diabetes Care 2007;30:14). This study is planned as an open, randomised pilot study of minimum 40 patients testing the feasibility of implementing the use of skin temperature measurement for prevention of recurrent diabetic foot ulcers in a specialist clinical setting in Norway. If this is the case, we are planning a larger study to examine if these measurements can contribute to reducing the number of recurrent ulcers in clinical practice in Norway. We are in addition using a cognitive motivational method to examine if this model can increase the use of the temperature measuring device.
Trial information was received from ClinicalTrials.gov and was last updated in April 2013.
Information provided to ClinicalTrials.gov by Oslo University Hospital.